Effects of JWA, XRCC1 and BRCA1 mRNA expression on molecular staging for personalized therapy in patients with advanced esophageal squamous cell carcinoma
Main Authors: | Wei, Bin, Han, Qin, Xu, Lijuan, Zhang, Xiaohui, Zhu, Jing, Wan, Li, Jin, Yan, Qian, Zhaoye, Wu, Jingjing, Gao, Yong, Zhou, Jianwei, Chen, Xiaofei |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469327/ |
Similar Items
-
JWA reverses cisplatin resistance via the CK2—XRCC1 pathway in human gastric cancer cells
by: Xu, W, et al.
Published: (2014) -
BRCA1 mRNA Expression as a Predictive and Prognostic Marker in Advanced Esophageal Squamous Cell Carcinoma Treated with Cisplatin- or Docetaxel-Based Chemotherapy/Chemoradiotherapy
by: Gao, Yong, et al.
Published: (2013) -
JWA regulates human esophageal squamous cell carcinoma and human esophageal cells through different mitogen-activated protein kinase signaling pathways
by: LIN, JIE, et al.
Published: (2014) -
XRCC3 is a promising target to improve the radiotherapy effect of esophageal squamous cell carcinoma
by: Cheng, Jingjing, et al.
Published: (2015) -
ING4 regulates JWA in angiogenesis and their prognostic value in melanoma patients
by: Lu, J, et al.
Published: (2013)